TELA Bio (TELA) EPS (Diluted) Growth (1y) (2020 - 2026)
TELA Bio (TELA) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.96% |
| 10 | TELA Bio | 36.34 Mn | 5.92 Mn | 13.94 Mn | 10.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.32% |
| Mar 31, 2026 | 13.86% |
| Dec 31, 2025 | -118.48% |
| Sep 30, 2025 | 54.89% |
| Jun 30, 2025 | 57.18% |
| Mar 31, 2025 | -8.04% |
| Dec 31, 2024 | 266.92% |
| Sep 30, 2024 | 10.73% |
| Jun 30, 2024 | 3.96% |
| Mar 31, 2024 | 64.65% |
| Dec 31, 2023 | -9.06% |
| Sep 30, 2023 | 26.25% |
| Jun 30, 2023 | 30.68% |
| Mar 31, 2023 | 15.23% |
| Dec 31, 2022 | -3.35% |
| Sep 30, 2022 | 18.37% |
| Jun 30, 2022 | 24.58% |
| Mar 31, 2022 | -19.50% |
| Dec 31, 2021 | 9.52% |
| Sep 30, 2021 | 82.08% |